Investor Overview

Corporate Profile
ContraFect Corporation is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. Due to drug-resistant and newly emerging pathogens, hospital acquired infections are currently the fourth leading cause of death in the United States, following heart disease, cancer and stroke. We intend to address drug-resistant infections using our therapeutic product candidates from our lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses (regions that are not prone to mutation).
Stock Quote
ExchangeNASDAQ CM (US Dollar)
Price$2.20
Change (%) Stock is Down 0.1 (4.35%)
Volume27,972
Data as of 12/09/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Press ReleasesMore >>
DateTitle  
11/23/16ContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference
YONKERS, NY -- (Marketwired) -- 11/23/16 -- ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, announced today that Steven C. Gilman, PhD, the Company's Chairman and CEO, will participate in an analyst-led fireside chat at the 28th Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016 at... 
 Printer Friendly Version
11/17/16ContraFect Awarded $2.1 Million PRMRP Grant to Support Development of CF-301
YONKERS, NY -- (Marketwired) -- 11/17/16 -- ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that it has been granted a $2.1 million Technology/Therapeutic Development Award through the US Department of Defense Peer Reviewed Medical Research Program (PRMRP). The Techn... 
 Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever ContraFect Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share

X
| E-mail Alerts E-mail Alerts | IR Contacts Contact IR | Financial Tear Sheet Tear Sheet